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ABSTRACT 1 
Scope: Previous systematic reviews suggest beneficial effects of flavonoids on biomarkers of 2 
CVD risk, but have overlooked the impact of dose-response or food complexity. The aim of 3 
the present study was to examine the relative impact of composition, flavonoid structure and 4 
dose. 5 
Methods and Results: MEDLINE, EMBASE, and Cochrane were searched for RCTs of 6 
flavonoids or flavonoid-rich foods/extracts. Flavonoid composition was established using 7 
USDA and Phenol-Explorer databases. Effects of six flavonoid subgroups on endothelial 8 
function (flow mediated dilation; FMD), and blood pressure (systolic and diastolic; SBP and 9 
DBP) were assessed by random effects meta-analyses and regression analyses. Meta-analyses 10 
of combined flavonoid subclasses showed significant improvements in FMD [chronic, 0.73% 11 
(0.17, 1.30) 14 RCTs; acute, 2.33% (1.58, 3.08) 18 RCTs] and BP [SBP, -1.46mmHg (-2.38, 12 
-0.53) 63 RCTs; DBP, -1.25mmHg (-1.82, -0.67) 63 RCTs]. Similar benefits were observed 13 
for the flavan-3-ol, catechol flavonoids (catechins, quercetin, cyanidin etc.), procyanidins, 14 
epicatechin, and catechin subgroups. Dose-response relationships were nonlinear for FMD 15 
(R
2
≤0.30), with greater associations observed when applying polynomial regression analyses 16 
(R
2
≤0.72); there was no indication of a dose-response for BP. 17 
Conclusions: The present analysis suggests that flavonoid bioactivity does not follow a 18 
classical linear dose-response association and this may have important biological 19 
implications.  20 
21 
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1 Introduction 22 
 Evidence from epidemiological studies and randomised controlled trials (RCTs) together 23 
with in vitro data on vascular bioactivity support a potential role for some flavonoids in the 24 
reduction in risk of cardiovascular disease [1-3]. Although numerous short-term RCTs have 25 
been published to date, their findings have often been inconsistent, most likely as studies 26 
have often been idealistically designed and/or interpreted. Intervention studies on plant-27 
derived food products are particularly complex as the content of plant bioactives fed are 28 
chemically diverse and extremely variable relative to pure preparations. Limitations in data 29 
reporting have also made systematically reviewing the data challenging. For many RCTs 30 
there has been inadequate assessment of flavonoid composition of either the foods fed or in 31 
analyses of the biological samples, limited-dose response analysis and inconsistencies in 32 
biomarkers measured across studies [4, 5]. In order to further progress our understanding of 33 
the bioactivity of flavonoids these potential limitations need to be explored.   34 
Flavonoids are a diverse group of polyphenolic compounds which have been 35 
traditionally subdivided into six major subclasses (Table 1). Previous meta-analyses have 36 
evaluated the effects of flavonoids based on a single flavonoid subclass within a food, such as 37 
flavan-3-ols (catechins) in chocolate, anthocyanins in wine, quercetin in onions [2, 6-8]. 38 
However this approach does not take into account the complex array of flavonoid compounds 39 
present within any given food product. For example, red wine is commonly identified as a 40 
rich source of anthocyanins; however, wine contains a complex array of flavonoids, and some 41 
wines may contain equivalent or greater amounts (mg/100g) of flavan-3-ols over 42 
anthocyanins [9]. Similarly, for many foods (e.g., tea, wine, chocolate), polymeric flavonoids 43 
such as tannins or thearubigins (which are composed of repeating flavonoid units) are found 44 
in much higher concentrations than all the monomeric forms (which are composed of one 45 
flavonoid) combined [9-11]. Therefore, dietary interventions are often misclassified as 46 
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providing one flavonoid source over another, thus obscuring the effects in meta-analysis. The 47 
present review compares the conventional strategy of reporting the biological effect of one 48 
flavonoid constituent within a food product, with one which utilises available flavonoid 49 
databases to examine the impact of total flavonoid composition, chemical structure and dose, 50 
including polymer and monomer content (Table 1). The aim of the present study was to 51 
examine the relative impact of composition, flavonoid structure and dose, with the objective 52 
of highlighting gaps in the present literature, developing new insights into flavonoid 53 
bioactivity and new hypotheses for future investigation.  54 
 55 
2 Materials and methods 56 
We included RCTs of parallel or crossover design that randomised adult humans to a 57 
nutrition intervention involving flavonoids or flavonoid-rich foods/extracts compared to a 58 
control group, and which reported effects on established or emerging cardiovascular risk 59 
biomarkers; using methods as previously published [8] (and described in greater detail in the 60 
online supplementary data; Appendix 1). Briefly, our primary outcomes were flow mediated 61 
dilation (FMD) and blood pressure (BP) and we searched MEDLINE, EMBASE and the 62 
Cochrane Library databases. All included abstracts were identified independently by two 63 
reviewers and data were extracted independently from all included studies with discrepancies 64 
(if any) adjudicated by a third reviewer. 65 
The composition of each intervention included in these analyses was individually 66 
extracted from each manuscript, when present, and if no compositional data was provided, it 67 
was established using comprehensive online  flavonoid databases [9, 10]. Data on twenty six 68 
flavonoid species across 6 subclasses were initially extracted for the interventions used in 69 
each study (Table 1) using the USDA flavonoid database [10], with Phenol-Explorer used 70 
where data were incomplete or missing [9].  A more detailed description of the methods 71 
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utilised for establishing the flavonoid compositions of the included RCTs is provided as 72 
online supplementary material (Appendix 2). This led to 6 intervention classifications based 73 
on unique compositional characteristics of the flavonoid-rich food/extract fed in the 74 
intervention studies (further details regarding trial classifications is provided in the online 75 
supplement materials; Appendix 3). Briefly studies were classified by total flavonoids and the 76 
most abundant individual subclass constituent (both including and excluding polymers), as 77 
well as by unique B- and C-ring constituent structures; where total cumulative dose was 78 
established for each.  79 
Random effects meta-analyses (using Review Manager (RevMan) Version 5.0. 80 
Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011) were carried 81 
out for total flavonoids or most abundant flavonoid or subclass (online supplement, Appendix 82 
3) vs. control, for the 3 primary outcomes (FMD, SBP and DBP) including all relevant RCTs. 83 
Where a statistically significant effect of flavonoids or a subclass was seen, the dose-response 84 
was explored via linear and polynomial regression analyses in Excel (Microsoft Excel; 85 
Microsoft Corp, Seattle, WA).  86 
 87 
3 Results 88 
3.1 Data extraction  89 
We assessed 8893 titles and abstracts for inclusion in the systematic review.  Of these, 487 90 
were collected as full text and assessed for inclusion. Of these 184 intervention studies were 91 
included for composition extraction. Compositional analysis for establishing dose-response 92 
was possible for 174 studies (for details see online supplementary materials, Appendix 4 and 93 
5). Of these studies, 63 provided data on blood pressure, 32 on FMD, with 77 interventions 94 
included in total (as some reported both FMD and BP).    95 
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Of the included  intervention studies, where compositional analyses were possible, 96 
unique meta-analysis for total flavonoids, most abundant subclass (C- and B-ring 97 
classification) and most abundant subclass constituent (including and excluding polymers) 98 
was performed (description of the individual RCT sub-classifications is provided as online 99 
supplementary material; Appendix 5&6). The majority of included interventions fed 100 
chocolate (20%), tea (21% green, 9% black), red wine (15%), and berries or grapes (15%) 101 
and most included studies were interventions involving the flavan-3-ol subclass (51% of 102 
studies), catechol/dihydroxy flavonoids (68% of studies) or the flavan-3-ol subclass 103 
constituent epigallocatechin gallate (15%). When we included polymers in the analyses, 51% 104 
of the studies were classified as flavonoid polymer interventions. In the analysis of dose-105 
response, the majority of interventions fed well below 500mg/d of total polymeric and 106 
monomeric constituents combined, and/or 200mg/d monomeric constituents (Table 2). 107 
 108 
3.2 FMD response  109 
In pooled analysis of all flavonoid interventions (including both monomeric and polymeric 110 
forms), FMD improved both acutely [2.33% (1.58, 3.68)] and chronically [0.73% (0.17, 111 
1.30)] (Figure 1A and 1B, respectively). When we further examined subclasses and 112 
individual constituents, the magnitude of the FMD response was greater for several flavonoid 113 
subclass constituents (Table 3). In particular, the acute FMD responses for epicatechin, 114 
catechin or procyanidins ranged from 3.22% to 3.38%, compared to analyses which grouped 115 
subclasses together, such as total flavonoids, flavan-3-ols and catechol flavonoids (ranging 116 
from 2.33 to 2.81%; Table 3.1). The responses for chronic FMD followed a similar pattern 117 
(Table 3.2), although the magnitude of the acute FMD effect was greater (ranging from 118 
2.33% to 3.38 % for acute FMD vs. 0.73% to 2.32% for chronic FMD).  119 
 120 
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3.3 BP response 121 
When all flavonoid interventions were pooled, there was a significant reduction in BP 122 
observed; SBP [-1.46mmHg (-2.38, -0.53)] and DBP [-1.25 mmHg (-1.82, -0.67)](Figure 2). 123 
Similar to the effects observed for the acute FMD response (Table 3.1), BP response was 124 
greatest for epicatechin, quercetin and procyanidins (-1.67 to -2.36mmHg), compared to 125 
analyses that grouped subclass constituents together, such as total flavonoids, flavan-3-ols or 126 
catechol flavonoids (-1.24 to -1.69mmHg) (Tables 3.3-3.4).  127 
 128 
3.4 Dose-response 129 
There was no indication of a linear dose-response (R
2
<0.17) for acute FMD across the entire 130 
dose range for total flavonoids (Figures 3 A&B), flavan-3-ols (Figure 3C), catechol 131 
flavonoids (Figure 3D), procyanidins (Figure 3E) or epicatechin (Figure 3F). Non-linear 132 
dose-response associations (inverted-U-shaped and bimodal) were indicated in polynomial 133 
regression analyses for total flavonoids (R
2
=0.20), flavan-3-ols (R
2
=0.28), procyanidins 134 
(R
2
=0.51), and epicatechin (R
2
=0.31); where FMD response increased in magnitude with 135 
increasing dose only at the lower intake levels (e.g., doses<1g/d for total flavonoids and 136 
procyanidins or doses<200mg/d for monomeric forms).  There was also no suggestion of a 137 
linear dose-response (R
2
<0.13) for chronic FMD across the entire dose range for total 138 
flavonoids (Figures 4 A), flavan-3-ols (Figure 3C), procyanidins (Figure 3E) or epicatechin 139 
(Figure 3F), but a linear dose response was observed for total monomeric flavonoids 140 
(R
2
=0.23) and catechol flavonoids (R
2
=0.3), where FMD response decreased with increasing 141 
flavonoid dose. Similar to acute FMD response, non-linear dose-response associations were 142 
observed in polynomial regression analyses for total flavonoids (R
2
>0.34), flavan-3-ols 143 
(R
2
=0.26), catechol flavonoids (R
2
=0.33), procyanidins (R
2
=0.72), and epicatechin 144 
(R
2
=0.59); where inverted-U-shaped, U-shaped and bimodal dose-responses were indicated. 145 
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For both SBP and DBP there was no evidence of either a linear or non-linear dose-146 
response relationship (P<0.07 and P<0.17, respectively) across the entire dose range for 147 
flavonoid class, subclass or subclass constituent (Figures 5&6).  148 
 149 
4 Discussion  150 
Our data reinforce the findings from previous systematic reviews [2, 6, 8, 12, 13] 151 
regarding the beneficial effects of specific flavonoid sub-classes on the acute and chronic 152 
FMD response. On the basis of our data, flavan-3-ols, catechol (B-ring) flavonoids, 153 
procyanidins and epicatechin appear to exert this effect to varying extents, suggesting effects 154 
on FMD may not be confined to a single flavonoid subclass or food source. From the present 155 
dataset it was not possible to make inferences regarding the specific compositional 156 
breakdown of the polymers within the intervention foods, largely because both RCTs and 157 
food composition databases currently lack this level of detail. In addition, it is not possible 158 
from this dataset to establish if the effects observed for procyanidins are the result of the 159 
procyanidins themselves or monomeric species within procyanidin-rich foods.   160 
Crucially, our data suggest that some classes of flavonoids appear to have differential 161 
magnitudes of biological activity depending on the dose ingested, and specifically for flavan-162 
3-ols, catechol flavonoids, procyanidins, and epicatechin. Although none of these present 163 
subgroupings are distinctively unique, our dataset suggests that the effect of different 164 
subclasses of flavonoids may differ across intake level for FMD and BP. For example, there 165 
was little indication of a dose-response across the entire dose range (1mg/d to 2.6g/d) for 166 
FMD when flavonoid interventions were grouped together (monomers and polymers); 167 
however, there were indications of dose-responses within defined dose ranges (e.g., below 168 
200mg/d for flavonoid monomers and below 1g/d for total flavonoids and flavonoid 169 
polymers) within some of the flavonoid sub-classifications. Specifically, acute FMD response 170 
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appeared to increase with increasing doses of procyanidins at doses below 500mg/d and 171 
catechol flavonoids below 200mg/d. In addition chronic FMD response appeared to increase 172 
with increasing dose for procyanidins at doses up to 400mg/d and above 600mg/d and flavan-173 
3-ols and catechol flavonoids at doses below 100mg/d.  174 
In line with previous systematic reviews [2, 6, 12] we also observed an overall 175 
beneficial effect of flavonoids on BP and our data suggest this relationship is particularly 176 
consistent for the flavan-3-ols and the catechol B-ring flavonoids as subclasses, and 177 
procyanidins and epicatechin as subclass constituents. There was little evidence suggesting 178 
this effect was dose-dependent. An unexpected finding was that improvements in BP (both 179 
SBP and DBP) were strongest at lower doses and not apparent at the highest doses, however 180 
this relationship between flavonoids on BP has been reported in tea interventions previously 181 
[14]. Together these data suggest that in addition to distinguishing between the effects of 182 
polyphenol polymers relative to monomers in future studies, it is imperative that 183 
interventions also explore dose-response. 184 
The present systematic review indicates that few ‘high-dose’ flavonoid interventions 185 
have been conducted to date (i.e., >500mg/d total polymeric and monomeric forms or 186 
>200mg/d total monomeric forms); which has left the present interpretation of dose-response 187 
somewhat incomplete. The present graphical indications of inverted-U-shaped, U-shaped and 188 
bimodal dose-responses should therefore be interpreted with caution. In addition, the majority 189 
of flavonoid interventions conducted to date have primarily fed foods in which polyphenol 190 
polymers and catechol B-ring flavonoids are the predominant forms (>50%). Therefore it is 191 
important that future studies establish the effects for polymers and monomers across a large 192 
range of doses (and particularly at higher doses), in addition to establishing the effects of 193 
polymeric vs. monomeric flavonoids in pure forms and in foods. Future studies should also 194 
consider the involvement of ‘non-flavonoid’ phenolic compounds (e.g., cinnamates and 195 
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chlorogenic acids) which often contribute substantially to the composition of flavonoid-rich 196 
foods. Importantly, these future RCTs must also provide complete detailed flavonoid 197 
compositional analysis. 198 
The interpretation of many published RCTs has been challenging as a result of issues 199 
with study design. Highlighting these design limitations is essential, if progress towards 200 
understanding the bioactivity of flavonoids is to be achieved. Even though meta-analysis may 201 
not be the most appropriate tool for establishing these limitations, it does allow for the 202 
realisation of inherent ‘gaps’ within the literature, and in this particular instance our lack of 203 
knowledge regarding dose-response. It is important to note that polynomial regression may 204 
appear to provide a better data fit in some circumstances, but high-dose studies are currently 205 
lacking from many of the available data sets, therefore leaving the regression analyses 206 
sensitive to outliers.  207 
In the present dataset, theaflavins and thearubigins, procyanidins and condensed 208 
tannins, and various gallate conjugates of catechin were each grouped together (respectively), 209 
as the complexities of their structures did not allow for their classification into single 210 
subclass. Together these compounds comprise a significant proportion of the polyphenols in 211 
flavonoid-rich foods, such as tea, chocolate and wine [9-11]. Ultimately the definitive 212 
contribution of polyphenol polymers to the bioactivity of flavonoids is difficult to ascertain, 213 
as there is a lack of compositional data provided in available RCTs and flavonoid databases. 214 
Even though more extensive publically available databases will undoubtedly be available in 215 
the near future, and recent progress with composition databases has made this review 216 
possible, there are many inaccuracies with this type of post-hoc analysis; particularly since 217 
plants and therefore plant-derived foods are dynamic and the amounts of polyphenols and 218 
flavonoids will vary depending on growing conditions (sunlight, water, nutrient and pH 219 
composition of soil) and the country of origin. The only accurate way to determine the effect 220 
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of flavonoid composition on a physiological response is to conduct a direct compositional 221 
analysis on the specific intervention foods, and at the times prior to and over the course of the 222 
RCT. This is a significant limitation with the majority of previous RCTs in this field. In the 223 
present systematic review only 22% of included studies provided comprehensive flavonoid 224 
compositional analysis, while 34% provided limited, incomplete or targeted analysis and 44% 225 
provided no compositional data at all. Other general inherent weaknesses of published 226 
intervention data include low participant numbers, poor reporting of data, lack of long-227 
duration interventions, limited dose-response analysis, and lack of pharmacokinetic data. 228 
Conversely, an important conceptual limitation of the present review is the assumption that 229 
intervention studies feeding different food sources of flavonoids can be grouped together, 230 
thus suggesting food components act independently and that a pure flavonoid would act 231 
similarly to a flavonoid in a fruit or a processed food. Obviously this is not the case and we 232 
acknowledge that this approach also comes with limitations. The utility of the present 233 
analysis was to develop novel hypotheses on the relative importance of different flavonoid 234 
sub-groupings. 235 
To our knowledge this is the first systematic review of flavonoid interventions to 236 
focus on dose-response and also the first to explore the actions of catechol B-ring flavonoids 237 
as a unique flavonoid sub-grouping. In doing so, we have observed some unique associations 238 
which should help focus future RCTs in addition to cell and animal research. In particular, it 239 
is clear that at present there is an incomplete picture of dose-response across intervention 240 
studies. Importantly our data suggest that for some classes of flavonoid there may be a 241 
maximal biological effect or dose threshold. This was particularly apparent where bioactivity 242 
did not follow a linear dose-response. The indication of differential flavonoid responses 243 
across the dose range is representative of the reported bimodal bioactivity of flavonoids in 244 
some previous in vitro cellular and molecular model investigations [15-17] and has more 245 
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recently been reported in a large prospective US cohort of nearly 100,00 adult men and 246 
women (of mean age >69 years)[18]. Although this observation in the present systematic 247 
review is interesting and may have significant implications, the present analysis is 248 
extrapolative in nature and designed only to form hypotheses; RCTs specifically designed to 249 
explore dose-response effects are necessary to establish if this is indeed a ‘true effect’. If 250 
flavonoids do however have a true dose threshold or bimodal dose-response, systematic 251 
reviews combining high and low dose interventions together, without accounting for dose-252 
response, may overlook potentially important physiological effects of flavonoids. More 253 
importantly, if different subclasses of flavonoids have either ‘inverted U-shaped’, ‘U-shaped’ 254 
or bimodal bioactivity, this could have very significant biological/health implications.  255 
In conclusion, this systematic review approach facilitated an exploration into the 256 
dose-response relationships of flavonoids across current RCTs, providing insight into the 257 
effects of flavonoids on biomarkers of CVD risk. The main findings indicate that there may 258 
be non-linear dose effects of flavonoid monomers and polymers and further studies are 259 
needed to establish the impact of these associations on health and disease. 260 
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Table 1. Structural configuration of common dietary flavonoids: subclass, subclass 
constituent and B-ring configuration. 
Flavonoid 
(Subclass) 
Subclass Structure 
Subclass 
constituent 
B-Ring Configuration 
R
1
 R
2
 R
3
 
Flavanones 
CA
B
R
3
R
1
R
2
O
OH
OH
O
 
Naringenin H OH H 
Eriodictyol OH OH H 
Hesperetin OH O-CH3 H 
Taxifolin OH OH H 
Kaempferol  H OH H 
Flavonols 
R
3
R
2
R
1
O
OH
OH
OH
O
 
Quercetin  OH OH H 
Myricetin  OH OH OH 
Isorhamnetin  O-CH3 OH H 
Apigenin  H OH H 
Flavones 
R
3
R
1
R
2
O
OH
OH
O
 
Luteolin  OH OH H 
Tricetin  OH OH OH 
Chrysoeriol O-CH3 OH H 
Epicatechin OH OH H 
Flavan-3-ols R
1
R
3
R
2
OH
OH
OH
O
 
Epicatechin 
gallate 
OH OH H 
Epigallocatechin OH OH OH 
Epigallocatechin 
gallate 
OH OH OH 
Cyanidin OH OH H 
Anthocyanins/
Anthocyanidins 
R
3
R
1
R
2
OH
OH
OH
O
+
 
Delphinidin OH OH OH 
Peonidin O-CH3 OH H 
Pelargonidin H OH H 
Malvidin O-CH3 OH O-CH3 
Petunidin O-CH3 OH OH 
 
 
 
Procyanidins 
 
 
 
NA 
 
 
 
NA 
 
 
 
NA 
4Polymers 
 
OH
OH
OH
OH
OH
O
OH
OH
OH
OH
OH
O
OH
OH
OH
O
OH
OH
O
10+
 
Tannins NA NA NA 
Theoflavins NA NA NA 
    
OH, hydroxyl conjugate; O-CH3, methoxly conjugate; polymer, composed of repeating 
structural units; 
1-3
R, functional group identifier. 
4
Structure provided for the polymer 
subclass is one example of a polyphenol polymer; however, polyphenol polymers can 
have tremendous structural diversity.  
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Table 2. Dose characteristics of the flavonoid constituents utilised in the 
intervention studies 
1
Subgrouping  
Proportion (as %) of interventions vs. dose 
(mg/d) 
total flavonoids (monomeric & polymeric) 68% ≤ 500 34%  ≤ 200 
total flavonoids (monomeric only) 65% ≤ 200 38% ≤ 100 
Mean and max dose of subclass constituents Mean  
(mg/d, ±SD) 
Max 
(mg/d) 
polymers 369 ± 367 2,080 
epigallocatechin gallate 259 ± 222 1,038 
quercetin 512 ± 438 1,000 
catechin 67 ± 55 149 
cyanidin  175 ± 171 500 
epicatechin  159 ±190 556 
1
Subgroupings include total flavonoid monomers, total flavonoid monomers and 
polymers together and individual flavonoid subclasses (e.g., polymers, 
epigallocatechin gallate, quercetin, catechin, cyanidin, epicatechin).   
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Table 3.  The effect of flavonoids (class), flavonoid subclass and subclass 
constituents on FMD and BP
1
 
Risk factor Subgroup Analysis Mean effect (%)
1
 n 
I
2 
(%) 
P-value 
3.1.  FMD Acute
2
 total flavonoids 2.33 [1.58, 3.08] 18 86 P<0.00001 
 flavan-3-ols 2.81 [1.92, 3.69] 13 88 P≤0.00001 
 catechol flavonoids 2.47 [1.67, 3.28] 16 88 P≤0.00001 
 procyanidins 3.38 [2.19, 4.58] 9 92 P≤0.00001 
 epicatechin 3.22 [1.94, 4.50] 9 88 P≤0.00001 
 catechin  3.22 [2.66, 3.78] 2 15 P<0.00001 
3.2.  FMD Chronic
2 total flavonoids 0.73 [0.17, 1.30] 14 58 P=0.01 
 
flavan-3-ols 1.03 [0.58, 1.48] 12 30 P≤0.00001 
 
catechol flavonoids 0.75 [0.15, 1.35] 13 61 P≤0.01 
 
procyanidins 1.09 [0.56, 1.61] 10 40 P<0.0001 
 epicatechin 0.94 [0.47, 1.42] 9 32 P=0.0001 
 catechin 2.32 [0.97, 3.68] 2 0 P=0.00008 
3.3.  Chronic SBP
3 total Flavonoids -1.46 [-2.38, -0.53] 63 80 P=0.002 
 
flavan-3-ols -1.50 [-3.01, 0.01] 37 84 P=0.05 
 
catechol flavonoids -1.69 [-2.80, -0.58] 45 83 P=0.003 
 
procyanidins -2.33 [-3.81, -0.85] 26 84 P=0.002 
 
epicatechin -2.36 [-4.54, -0.18] 21 89 P=0.03 
3.4.  Chronic DBP
3 total Flavonoids -1.25 [-1.82, -0.67] 63 70 P≤0.0001 
 
flavan-3-ols -1.24 [-2.00, -0.49] 38 65 P=0.001 
 
catechol flavonoids -1.24 [-1.89, -0.58] 45 70 P=0.0002 
 procyanidins -1.83 [-2.82, -0.85] 26 77 P≤0.0003 
 epicatechin -1.67 [-2.76, -0.58] 21 72 P=0.003 
 
quercetin -1.76 [-3.54, 0.02] 5 40 P=0.05 
Class, total flavonoids; subclass, flavan-3-ols and catechol flavonoids; subclass 
constituents, procyanidins, epicatechin, catechin, and quercetin. 
1
Meta-analyses 
utilised fixed effects mean differences, to allow assessment of p-value for difference 
between subgroups. 
2
Inverse variance, mean difference IV, Random, 95% Cl. 
3
mmHg, IV Random, 95% Cl.  
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Figure Legends: 
 
Figure 1. FMD response to all flavonoid interventions (total flavonoids: 
monomeric and polymeric forms). Data are presented (as % change) for random 
effects meta-analysis conducted using inverse variance for A, acute (90-150 
minutes) FMD response (n=18) and B, chronic (≥2 weeks intervention) FMD 
response (n=14). FMD, flow mediated dilation. 
 
Figure 2. Diastolic blood pressure (DBP) response (n=63) to all flavonoid 
interventions (total monomeric and polymeric flavonoids). Data are presented (as 
change in mmHg) for random effects meta-analysis inverse variance for chronic 
(≥2 weeks intervention) diastolic blood pressure response (mmHg). 
 
Figure 3. Acute FMD (%) dose-response (mg/d)
1
. Dose-response plots represent % 
change in FMD response presented for random effects meta-analysis conducted 
using inverse variance relative to dose in mg/d. Acute, 90-150 minutes; FMD, flow 
mediated dilation. Z-scores and p-values were derived from meta-analyses utilising 
fixed effects mean differences and R
2
 coefficient of determination was derived 
from dose-response regression plots. 
 
Figure 4. Chronic FMD (%) dose-response (mg/d)
1
. Dose-response plots represent 
% change in FMD response presented for random effects meta-analysis conducted 
using inverse variance relative to dose in mg/d. Chronic, after a minimum of 2 
weeks intervention; FMD, flow mediated dilation. Z-scores and p-values were 
derived from meta-analyses utilising fixed effects mean differences and R
2
 
coefficient of determination was derived from dose-response regression plots. 
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Figure 5. Chronic SBP dose-response
1
. Dose-response plots represent change in BP 
(mmHg), presented for random effects meta-analysis conducted using inverse 
variance relative to dose in mg/d. Chronic, a minimum of at least 2 weeks 
intervention. Z-scores and p-values were derived from meta-analyses utilising fixed 
effects mean differences and R
2
 coefficient of determination was derived from 
dose- response regression plots. 
 
Figure 6. Chronic DBP dose-response
1
. Dose-response plots represent change in 
BP (mmHg), presented for random effects meta-analysis conducted using inverse 
variance relative to dose in mg/d. Chronic, a minimum of at least 2 weeks 
intervention. Z-scores and p-values were derived from meta-analyses utilising fixed 
effects mean differences and R
2
 coefficient of determination was derived from 
dose-response regression plots. 
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Figure 3.  
  
A. Total Flavonoids (including polymeric forms; dose 1.8mg-2.6g/d; n=18; Z=6.10, P<0.00001) 
Regression R2
Linear 0.00
2pt polynomial 0.15
3pt polynomial 0.20
B. Total Flavonoids (monomeric forms only; 4.0-551.0mg/d; n=18; Z=6.10, P<0.00001) 
Regression R2
Linear 0.13
2pt polynomial 0.15
3pt polynomial 0.15
C. Flavan-3-ols (monomeric forms only; 0.4-249.5 mg/d; n=13; Z=6.24, P≤0.00001) 
Regression R2
Linear 0.17
2pt polynomial 0.21
3pt polynomial 0.28
D. Catechol flavonoids (monomeric forms only; 0.4-549.5mg/d; n=16; Z=6.01, P≤0.00001) 
Regression R2
Linear 0.02
2pt polynomial 0.12
3pt polynomial 0.13
E. Procyanidins (including polymeric forms; 1.4mg-2.1g/d; n=9; Z=5.65, P≤0.00001) 
Regression R2
Linear 0.12
2pt polynomial 0.43
3pt polynomial 0.51
F. Epicatechin (monomeric forms only; 2.6-439.8mg/d; n=9; Z=4.92, P≤0.00001) 
Regression R2
Linear 0.15
2pt polynomial 0.31
3pt polynomial 0.31
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Figure 4.  
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Figure 5.  
  
A. Total Flavonoids (including polymeric forms; 106.0mg-2.3g/d; n=62; Z=3.10, P=0.002) 
Regression R2
Linear 0.06
2pt polynomial 0.09
3pt polynomial 0.11
B. Total Flavonoids (monomeric forms only; 7.0mg-1.0; n=60; Z=3.10, P=0.002) 
Regression R2
Linear 0.08
2pt polynomial 0.10
3pt polynomial 0.10
C. Flavan-3-ols (monomeric f rms only; 7.1mg-1.2g/d; n=37; Z=1.95,P=0.05)
Regression R2
Linear 0.02
2pt polynomial 0.02
3pt polynomial 0.04
D. Catechol flavonoids (monomeric forms only; 6.8mg-1.0g/d; n=45; Z=2.99, P=0.003)
Regression R2
Linear 0.05
2pt polynomial 0.07
3pt polynomial 0.07
E. Procyanidins (including polymeric forms; 21.0-805.0mg/d; n=26; Z=3.09, P=0.002) 
Regression R2
Linear 0.03
2pt polynomial 0.04
3pt polynomial 0.05
F. Epicatechin (monomeric forms only; 5.1-556.0mg/d; n=21; Z=2.12, P=0.03) 
Regression R2
Linear 0.15
2pt polynomial 0.17
3pt polynomial 0.15
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Figure 6.  
  
A. Total Flavonoids (including polymeric forms; 28.0mg-2.3g/d; n=62; Z=4.23, P<0.0001) 
Regression R2
Linear 0.04
2pt polynomial 0.05
3pt polynomial 0.06
B. Total Flavonoids (monomeric forms only; 7.0mg-1.0g/d; n=60; Z=4.23, P<0.0001) 
Regression R2
Linear 0.05
2pt polynomial 0.06
3pt polynomial 0.08
C. Flavan-3-ols (monomeric forms only; 7.1mg-1.2g/d; n=38; Z=3.22, P=0.001)
Regression R2
Linear 0.04
2pt polynomial 0.06
3pt polynomial 0.10
D. Catechol flavonoids (monomeric forms only; 6.8-556.0mg/d; n=45; Z=3.71, P=0.0002)
Regression R2
Linear 0.00
2pt polynomial 0.03
3pt polynomial 0.04
E. Procyanidins (including polymeric forms; 21.0-805.0mg/d; n=26; Z=3.66, P=0.0003
Regression R2
Linear 0.07
2pt polynomial 0.08
3pt polynomial 0.08
F. Epicatechin (monomeric forms only; 5.1-556.0mg/d; n=21; Z=3.01, P=0.003) 
Regression R2
Linear 0.07
2pt polynomial 0.08
3pt polynomial 0.11
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